1-Methyl-1,8-diazaspiro[4.5]decan-2-onehydrochloride, 250mg

5-Bromo-2-(methylamino)benzoic acid, 95.0%, 5g

4-Methyl-1,2,3-thiadiazole-5-carboxylic acid, 98.0%, 25g

4,4,5,5-Tetramethyl-2-(propa-1,2-dien-1-yl)-1,3,2-dioxaborolane, 95.0%, 1g

8-Azabicyclo[3.2.1]-octane-8-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3-endo)-, 95.0%, 250mg

4,4',4'',4''',4'''',4'''''-(9,10-Dihydro-9,10-[1,2]benzenoanthracene-2,3,6,7,14,15-hexayl)hexabenzoicacid, 98%, 5g

2,3,5-Trimethyl-4-nitropyridine N-Oxide>98.0%(GC)(T)250mg

2,2-Bis(4-chlorophenyl)-1,1-dichloroethane>98.0%(GC)1g

2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-AMINE, 95.0%, 100mg

4-(Azetidin-1-ylmethyl)benzonitrile, 95%, 5g

(2E)-1-(4-fluorophenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

3-nitrofenol, mínimo 99 %, para síntesis, 250 g, envase de vidrio

1,2,3-Trimethoxybenzene, 99.00%, 500g